Bio-Rad Laboratories, Inc. (BIO-B) — 10-Q Filings

10-Q Filings (6)

• Bio-Rad Swings to Q3 Loss on Equity Valuation Hit — Oct 29, 2025 Risk: high
  BIO-RAD LABORATORIES, INC. reported a net loss of $341.9 million for the three months ended September 30, 2025, a significant decline from a net income of $653.
• Bio-Rad Swings to Q2 Loss Amidst Challenging Market — Jul 31, 2025 Risk: high
  BIO-RAD LABORATORIES, INC. reported a net loss of $10.1 million for the second quarter of 2025, a significant decline from a net income of $10.0 million in the
• Bio-Rad Labs Files Q1 2025 10-Q — May 1, 2025 Risk: low
  Bio-Rad Laboratories, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first q
• Bio-Rad Labs Files Q3 2024 10-Q — Oct 31, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial performance and position, including detai
• Bio-Rad Laboratories Files Q2 2024 10-Q — Aug 2, 2024 Risk: low
  Bio-Rad Laboratories, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results for the second quarter and the first h
• Bio-Rad Laboratories, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
  BIO-RAD LABORATORIES, INC. (BIO-B) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Bio-Rad Laboratories, Inc. filed a 10-Q report for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX